In a memorandum to Medicare Advantage Organizations, the Centers for Medicare & Medicaid Services today announced new flexibility related to the use of step therapy in coverage of Part B services. The agency will allow MA plans to impose step therapy requirements for covered Part B drugs beginning in the 2019 plan year. In addition, the agency will permit those plans that also provide Part D coverage to require that a beneficiary try a Part D drug therapy prior to covering a Part B drug therapy. Federal law allows plans to use some utilization management tools, such as prior authorization; however, the agency has previously not allowed the use of step therapy, nor plans to manage coverage across the Part B and D benefits. The agency will require any plans that take advantage of this new flexibility to provide notice to beneficiaries, as well as additional care coordination services to support access to care. For more see the CMS factsheet.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services April 6 finalized updates and changes to its Medicare Advantage and Part D payment methodologies for calendar…
Headline
The Centers for Medicare & Medicaid Services should develop prior authorization measures for the Medicare Advantage Star Ratings Program to minimize care…
Headline
The Centers for Medicare & Medicaid Services today proposed changes to the Medicare Advantage and Medicare Part D programs, including implementing various…
Headline
The Centers for Medicare & Medicaid Services yesterday announced proposed changes to the risk adjustment model for Medicare Advantage organizations and…
Headline
Medicare Advantage organizations received $6.7 billion in risk adjustment payments in 2017 for diagnoses that were not supported by the medical record,…
Headline
The Centers for Medicare & Medicaid Services today published its star ratings for 2020 Medicare Advantage and prescription drug plans. Most people…